Development Trend and Prediction of Stem Cell Technology in China from the Perspective of Patent

Abstract

Objective To provide new ideas for the effective treatment of many serious diseases and to solve many major medical problems faced by mankind. Methods In this paper, the invention patents in the field of stem cells in China from 2010 to 2020 were taken as the research object, and the technology status quo in the field of stem cells was analyzed to predict the future development direction through quantitative analysis method. Results and Conclusion The development of stem cell technology in China is in a period of growth with great potential. Therefore, it is necessary to strengthen the ability of Chinese universities to combine production, education and research. Nowadays, the hotspots in stem cell technology are using culture medium to improve cell proliferation ability, production efficiency, and to induce differentiated cells. Meanwhile, the production efficiency of embryonic stem cells should be improved, and the immunomodulatory effect of embryonic stem cells can be exerted to screen drugs. Besides, the function of hematopoietic stem cells should be enhanced and apply mesenchymal cells in therapy. Since the potential technological gaps are the improvement of therapy, induced differentiation and efficiency of pluripotent stem cells, the improvement of progenitor cell proliferation and the control of cost, we should strengthen R&D investment in culture medium, embryonic stem cells and other technical fields, and achieve the purpose of reducing R&D costs and improving R&D efficiency.

Keywords

stem cell industry / technology efficiency matrix / patent metrological analysis / industry situation

References

[1] Chen Yun, Zou Yi, Shao Rong, et al. The research and enlightenment about development policy and regulation of american stem cell industry[J]. China Journal of Pharmaceuticals, 2018, 49 (12): 1733-1741.

[2] Lai Chiahong. A study on the technology development trend of thin film crystal liquid crystal display (TFT-LCD) industry: A patent analysis and life cycle perspective[D]. Taiwan: Chung Yuan University, 2003.

[3] Li Chunyan. The distinguishing methods of technology life cycle based on patent analysis[J]. Journal of Modern Information, 2012, 32 (2): 98-101.

[4] Wang Jinfeng, Wu Min, Yue Junju, et al. Research on the path of technology opportunity identification in the innovation process[J]. Information Studies: Theory & Application, 2017, 40 (8): 82-86.

[5] Chen Ying, Zhang Xiaolin. Research progress on construction of patent technology effect matrix[J]. Data Analysis and Knowledge Discovery, 2011 (11): 1-8.

[6] Han Ye, Liu Qiang, Qi Yan, et al. Analysis of the development trend of international research on stem cell from the perspective of patent[J]. World Sci-Tech R&D, 2019, 41 (4): 392-402.

[7] Xinhua net. World’s first fully automated stem cell induction culture equipment passes acceptance[EB/OL].(2018-05-16)[2021-01-21]. http://www.xinhuanet.com/politics/2018-05-16/C_1122838344.htm.

[8] Tang Ying, Feng Jun. Development and application of animal cell culture medium[J]. Chinese Journal of Clinical Rehabilitation, 2006 (41): 146-148.

[9] He Chuan, Liu Ting. Research progress in biological characteristics of mesenchymal stem cells[J]. Medical Journal of West China, 2020, 32 (1): 148-151.

[10] Zhang Qingyun, Dong Fang, Hideo Ema. Research advance on in vitro generation of human hematopoietic stem cells for transplantation[J]. Journal of Experimental Hematology, 2020, 28 (1): 320-324.

[11] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126 (4): 2346-2351.

[12] Jiang Liangxia, Chen Zhongliang, Yang Shihua. Progress in pluripotent stem cell differentiation and somatic cell transdifferentiation into cardiomyocy[J]. Chinese Bulletin of Life Sciences, 2014, 26 (7): 703-708.

[13] Xu Jiang, Wang Yongyu. Progress on cardiovascular progenitor cell induction, proliferation, differentiation and applications[J]. Chinese Journal of Cell and Stem Cell (Electronic Edition), 2019, 9 (2): 119-123.